BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pourafkari L, Tajlil A, Nader ND. Biomarkers in diagnosing and treatment of acute heart failure. Biomark Med 2019;13:1235-49. [PMID: 31580155 DOI: 10.2217/bmm-2019-0134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang ZM, Xie XY, Zhao Y, Zhang C, Liu Z, Liu LM, Zhu MW, Wan BJ, Deng H, Tian K, Guo ZT, Zhao XZ. Critical values of monitoring indexes for perioperative major adverse cardiac events in elderly patients with biliary diseases. World J Clin Cases 2022; 10(20): 6865-6875 [DOI: 10.12998/wjcc.v10.i20.6865] [Reference Citation Analysis]
2 Sadat-Ebrahimi SR, Aslanabadi N. Role of MicroRNAs in Diagnosis, Prognosis, and Treatment of Acute Heart Failure: Ambassadors from Intracellular Zone. Galen Med J 2020;9:e1818. [PMID: 34466598 DOI: 10.31661/gmj.v9i0.1818] [Reference Citation Analysis]
3 Aleksova A, Sinagra G, Beltrami AP, Pierri A, Ferro F, Janjusevic M, Gagno G. Biomarkers in the management of acute heart failure: state of the art and role in COVID-19 era. ESC Heart Fail 2021. [PMID: 34609075 DOI: 10.1002/ehf2.13595] [Reference Citation Analysis]
4 Zhao H, Cui W. Prognostic risk scores for patients with heart failure. Br J Hosp Med. [DOI: 10.12968/hmed.2021.0594] [Reference Citation Analysis]